How to Play Pfizer for 194% Gains into the New Year
I had big plans for this week’s video – but one stock stole the show, wiping out all of my other ideas.
See, the market’s expected “Biden Bump” quickly became the “COVID-19 vaccine bump” after Pfizer Inc. (NYSE: PFE) announced that its vaccine trial was 90% effective, sending ammunition through the markets on Monday that sparked the Dow’s biggest daily gain in five months and sent the S&P to new all-time highs.
PFE jumped 15% at Monday’s opening bell, as investors left their money market safe havens and piled into the pharmaceutical company after it took first place in the race to create a COVID vaccine.
It’s not, however, the only company taking steps forward. Another pharmaceutical company is holding its annual Healthcare Conference at 8 a.m. tomorrow, where it will make an announcement on its own vaccine progress. You can learn how to take advantage right here.
It doesn’t take a market expert to know that these stocks are fraught with profit potential.
And I’ve discovered a play on PFE that could generate 194% returns into the new year. You can find all the details in the video below…
There’s profit potential on the horizon… and I’m not just talking about Pfizer.
My colleague, Andrew Keene, is on a trading hot streak right now. Since October 6, he’s delivered 10 winning trade recommendations in a row – with peak gains of 410.53%!
See, Andrew has just discovered a way for anyone to leverage the biggest, fastest-moving, most explosive stocks on the planet. And each play he recommends has the potential to hand you over 400%.
His next recommendation is coming Monday. Stay tuned to learn how you can be on the list to receive it…